Trust SoCal Treatment Center

Psychedelic Substance Misuse

Compassionate, evidence-based treatment for lasting recovery

Medically reviewed by Rachel Handa, Clinical Director — Updated January 31, 2026

Approximately 4.7 million Americans aged 12 and older reported past-year LSD use as of the 2022 NSDUH, representing stable prevalence of classical psychedelic use.
Growing clinical research on therapeutic uses of psilocybin and LSD in treatment-resistant depression, PTSD, and other conditions has increased public perception of safety, sometimes overshadowing risks associated with non-medical use and self-medication.
Psychedelic-related emergency department visits remain relatively rare compared to other substances but are increasing in regions with high psychedelic use prevalence.

Varies by treatment plan

What Is Lysergic Acid Diethylamide (LSD) and Other Psychedelics Addiction?

Lysergic acid diethylamide (LSD), psilocybin mushrooms, mescaline (from peyote or San Pedro cactus), and other classical psychedelics produce profound alterations in perception, emotion, and cognition by acting as partial agonists at serotonin 5-HT2A receptors and through interactions with other serotonergic and glutamatergic systems. Unlike depressants or stimulants, classical psychedelics do not directly create physical dependence and withdrawal is not medically dangerous. However, psychological dependence, problematic use patterns, and significant psychiatric harm can occur. Some individuals use psychedelics to self-medicate for underlying mental health conditions, creating a problematic cycle of escalating use and worsening psychiatric symptoms. Additionally, certain individuals have underlying vulnerability to psychotic disorders, and psychedelic use can precipitate or exacerbate these conditions. Psychological dependence on the transcendent experiences, the social identity around psychedelic culture, or the self-medication for emotional pain can become a significant addiction pattern. At Trust SoCal, we recognize the psychiatric risks of psychedelic misuse and provide comprehensive assessment and treatment addressing both the addiction pattern and underlying mental health conditions.

Signs & Symptoms

Recognizing the signs of lysergic acid diethylamide (lsd) and other psychedelics addiction is the first step toward getting help. Common indicators include:

Possession of LSD (blotter paper, liquid, or crystals), psilocybin mushrooms, or other classical psychedelics
Frequent use of psychedelics (weekly or more frequent) despite stated intentions to use less frequently
Psychological symptoms persisting between uses including depersonalization/derealization disorder, visual disturbances ("flashbacks"), or ongoing perceptual disturbances
Acute psychiatric symptoms during or after use including anxiety, paranoia, or transient psychotic symptoms
Use as self-medication for depression, anxiety, trauma, or other mental health conditions
Continued use despite recognition of negative consequences or psychiatric deterioration
Preoccupation with psychedelic experiences and identity strongly organized around psychedelic culture
Neglect of work, school, relationships, or health due to psychedelic use and related behaviors

Health Effects

1Acute psychiatric reactions including anxiety, panic attacks, paranoia, and transient psychotic symptoms during intoxication that usually resolve as the drug is metabolized

2Triggering of underlying psychotic disorders in individuals with genetic vulnerability; onset of schizophrenia or other psychotic disorders temporally associated with psychedelic use

3Persistent depersonalization/derealization disorder lasting weeks, months, or longer after psychedelic use; some individuals develop chronic depersonalization even after minimal exposure

4Visual disturbances and hallucinogenic persisting perception disorder (HPPD) featuring visual snow, geometric patterns, or color shifts continuing between uses and potentially lasting years

5Suicidality, particularly among individuals using psychedelics to self-medicate for depression or trauma and experiencing mood destabilization

6Accidents or dangerous behavior while in the profoundly altered state of consciousness psychedelics produce (driving, dangerous climbing, etc.)

7Psychological distress from difficult experiences ("bad trips") that are not medically dangerous but are profoundly frightening

8Flashbacks or intrusive recollections of psychedelic experiences, particularly among those with underlying trauma or PTSD

Withdrawal & Detox

Classical psychedelics do not produce physical dependence or a medical withdrawal syndrome. However, individuals who use psychedelics frequently or as self-medication often experience psychological withdrawal characterized by dysphoria, anxiety, emotional numbness, and intense cravings to return to use to "get back to the transcendent state." Some individuals report that periods of abstinence are accompanied by re-emergence of depression, trauma symptoms, or anxiety that they had been using psychedelics to escape. The psychological withdrawal is similar in nature to that seen in other forms of behavioral or non-substance addictions.

Treatment at Trust SoCal

Treatment for problematic psychedelic use at Trust SoCal begins with comprehensive psychiatric assessment to evaluate for underlying or emergent psychiatric conditions, particularly psychotic disorders. Individuals with active psychosis require immediate psychiatric intervention with antipsychotic medication if indicated. The treatment approach depends on the nature and severity of the problematic use: For individuals with heavy use patterns and psychological addiction, CBT addresses the addiction cycle and builds healthier coping mechanisms. For individuals using psychedelics to self-medicate, treatment focuses on the underlying condition (depression, anxiety, PTSD, trauma) with evidence-based therapies and medication if indicated. Trauma-informed care is essential for those with histories of trauma. Group therapy provides peer support and helps normalize the experience of struggling with psychedelic misuse. Family therapy may address family patterns related to drug use and mental health. Aftercare planning includes ongoing psychiatric monitoring and engagement with mental health treatment.

Ready to Get Help?

Take the first step toward recovery today. Our admissions team is available 24/7.

(949) 280-8360 Verify Insurance Contact Us

Key Statistics

Approximately 4.7 million Americans aged 12 and older reported past-year LSD use as of the 2022 NSDUH, representing stable prevalence of classical psychedelic use.

Growing clinical research on therapeutic uses of psilocybin and LSD in treatment-resistant depression, PTSD, and other conditions has increased public perception of safety, sometimes overshadowing risks associated with non-medical use and self-medication.

Psychedelic-related emergency department visits remain relatively rare compared to other substances but are increasing in regions with high psychedelic use prevalence.

Related Addiction Types

DXM Addiction

Dextromethorphan (DXM) is a cough suppressant available over-the-counter in cough syrups, tablets, capsules, and powders that produces dissociative and hallucinogenic effects at doses far exceeding the therapeutic level. At therapeutic doses (15 to 30 mg), DXM suppresses cough by acting on the cough center in the medulla. At doses of 250 to 1,500+ mg—levels achievable through purchase of multiple bottles of cough syrup or pure powder—DXM acts as a noncompetitive antagonist at the NMDA receptor, producing powerful dissociative and psychotomimetic effects similar to phencyclidine (PCP). Recreational DXM use, colloquially called "robotripping" or "dexing," has escalated dramatically in the past two decades, particularly among adolescents and young adults, because the drug is legal, inexpensive, and accessible in any pharmacy or convenience store without age restriction in most jurisdictions. Chronic DXM abuse causes severe, often irreversible neurological damage, hepatotoxicity, and significant psychological dependence. At Trust SoCal, we provide comprehensive treatment addressing both the acute harms of DXM toxicity and the underlying psychological drives toward dissociative substance use.

Learn More

Marijuana Addiction

While marijuana is often perceived as harmless, cannabis use disorder is a recognized medical diagnosis that affects millions of Americans. Modern marijuana products are significantly more potent than those available even a decade ago, with THC concentrations in some concentrates exceeding 90%. Chronic, heavy use can lead to physical dependence, withdrawal symptoms upon cessation, and significant impairment in motivation, cognitive function, and mental health. Marijuana addiction is particularly prevalent among young adults and adolescents, and its normalization in popular culture often makes it difficult for individuals to recognize when their use has become problematic.

Learn More

MDMA/Ecstasy Addiction

MDMA (3,4-methylenedioxymethamphetamine), commonly known as ecstasy or molly, is a synthetic psychoactive drug that produces powerful feelings of emotional warmth, empathy, heightened sensory perception, and increased energy. It acts primarily by flooding the brain with serotonin, dopamine, and norepinephrine simultaneously. While MDMA is often perceived as a relatively safe "party drug," chronic use carries significant neurotoxic risks, particularly to the serotonin system, and can lead to psychological dependence characterized by compulsive use despite mounting consequences. Street-sold MDMA is frequently adulterated with methamphetamine, cathinones (bath salts), fentanyl, or other dangerous substances, adding unpredictable risks to every dose. The social contexts in which MDMA is commonly used, including music festivals, nightclubs, and social gatherings, create environmental triggers that can make cessation especially challenging. Trust SoCal provides compassionate, evidence-based treatment for MDMA addiction that addresses both the neurological damage and the behavioral patterns sustaining use.

Learn More

Therapies Used in Treatment

CBTCognitive Behavioral Therapy DBTDialectical Behavior Therapy EMDREye Movement Desensitization and Reprocessing MIMotivational Interviewing GGroup Therapy

Frequently Asked Questions

Can you become addicted to psychedelics if they don't cause physical dependence?

Yes. While classical psychedelics do not create physical dependence, psychological addiction is possible. Individuals can become psychologically dependent on the transcendent experiences, the social identity and community of psychedelic culture, or the use of psychedelics as self-medication for emotional pain. The psychological dependence can be strong enough to drive problematic use patterns despite negative consequences. Additionally, some individuals use psychedelics compulsively to manage underlying mental health conditions, creating a cycle of escalating use and psychiatric deterioration.

Can psychedelics trigger schizophrenia or other psychotic disorders?

Yes, in individuals with underlying genetic vulnerability to psychotic disorders. Some people experience psychotic symptoms for the first time during or shortly after psychedelic use. This may represent triggering of an underlying condition that would have emerged spontaneously, or it may represent precipitation by the drug. Regardless, the onset of psychosis temporally associated with drug use is a serious psychiatric emergency requiring immediate professional evaluation and treatment. If you have family history of schizophrenia, bipolar disorder, or other psychotic conditions, psychedelic use carries elevated risk.

What is depersonalization/derealization disorder from psychedelics?

Depersonalization/derealization disorder is a dissociative condition where the individual feels chronically detached from their body or surroundings, as if observing life from outside themselves or as if the world is not real. Some individuals develop this condition after psychedelic use and experience it persistently, even during abstinence. While LSD and psilocybin do not cause this in most users, individuals with certain neurobiological vulnerabilities appear at higher risk. Treatment involves psychiatric evaluation, addressing any underlying anxiety or trauma, and in some cases medication management of anxiety.

Is psychedelic self-medication a good idea?

No. While ongoing clinical research is exploring therapeutic applications of psychedelics in structured treatment settings, self-medication with non-medical psychedelics is not recommended. Self-medication often leads to escalating use without appropriate clinical monitoring, increases psychiatric risks, and delays access to evidence-based treatment. If you are using psychedelics to manage depression, anxiety, trauma, or other mental health conditions, contact Trust SoCal at (949) 280-8360 for professional assessment and access to evidence-based treatment.

Related Resources & Information

Treatment Programs

Evidence-Based Therapies

Get Help Now

Ready to Start Your Journey?

Recovery begins with a single step. Our compassionate team is here to guide you every step of the way.

Verify Insurance Now (949) 280-8360